Long Acting Injectables Explained - Info Session with Indivior + Camurus
As you are aware there are two new long-acting-injectable buprenorphine (LAI-B) products available in Australia:
1) Sublocade, by Indivior
2) Buvidal, by Camurus
Due to high level of interest in these new products, Insight is coordinating a free seminar/webinar featuring representatives from both Camurus and Indivior who will be providing an overview of their respective products.
Each session will cover:
Technology behind the LAIs
Dosage / strengths / injection volumes
Blockade of LAI
Conversion of patients from Methadone / Suboxone to LAI
Demonstration of administration / video
Costs / benefits for patients
This event can be attended in person or as an online webinar. Registration is required for both options - please select the ticket type applicable to you during the registration.
Webinar participants will be emailed a special link to the webinar in the days preceding the event.
NB: Registration is limited to Qld-based AOD health workers only, and priority will be given to staff employed within OST clinics.
Please note, this webinar will not be film-recorded, and is not catered (tea and coffee available only).
We hope you can join us!
Insight: Centre for AOD Training and Workforce Development